• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

HRS 2013

HRS13: Arrhythmia Research Technology touts new ECG device

May 15, 2013 By Ingrid Mezo Leave a Comment

HRS13: Arrhythmia Research Technology touts new ECG device

Arrhythmia Research Technology‘s (NYSE:HRT) Signal-Averaged Electrocardiography device is 1 of only 2 ECG tests that can predict ventricular arrhythmias in patients with prior heart attacks, data from an NIH-funded multi-center clinical trial proves.

Filed Under: Diagnostics, News Well Tagged With: Arrhythmia Research Technology Inc., Cardiac Rhythm Management, Heart Rhythm Society, HRS 2013

HRS13: Endosense’s force-sensing ablation catheter

May 15, 2013 By Ingrid Mezo Leave a Comment

HRS13: Endosense's force-sensing technology improves safety and effectiveness of ablation catheters

Geneva-based Endosense’s proprietary contact force technology improves efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, according to new study data released last week at the annual Heart Rhythm Society meeting.

Filed Under: News Well Tagged With: Cardiac Rhythm Management, Endosense SA, Heart Rhythm Society, HRS 2013

HRS2013: Sorin’s dual-chamber ICDs boast lower inappropriate shock rates

May 13, 2013 By Ingrid Mezo Leave a Comment

HRS2013: Sorin's dual-chamber ICDs boast lower inappropriate shock rates

Patients with Sorin Group (BIT:SRN) dual-chamber implantable cardioverter defibrillators had significantly fewer inappropriate shocks than patients with standard single-chamber devices, according to new clinical data.

Filed Under: News Well Tagged With: Cardiac Rhythm Management, Heart Rhythm Society, HRS 2013, Sorin Group

HRS2013: Boston Scientific touts battery life data

May 13, 2013 By Ingrid Mezo Leave a Comment

HRS13: Boston Scientific touts battery life data

Recent study data proves longer battery life of Boston Scientific‘s (NYSE:BSX) implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators, helping keep patients out of the hospital and reduce risk of infections and complications, the company claimed last week.

Filed Under: News Well Tagged With: Boston Scientific, Cardiac Rhythm Management, Heart Rhythm Society, HRS 2013

HRS13: Medtronic to seek expanded CRT indication on biventricular pacing data

May 13, 2013 By Ingrid Mezo Leave a Comment

HRS13: Medtronic seeks expanded CRT device indication

Medtronic (NYSE:MDT) plans to use new study results to ask the FDA to expand the indication for its cardiac resynchronization therapy devices, to include patients with atrioventricular block and left ventricular systolic dysfunction.

Filed Under: News Well Tagged With: Cardiac Rhythm Management, Clinical Trials, HRS 2013

HRS 2013 pre-meeting reflections

May 10, 2013 By MassDevice Leave a Comment

By Westby G. Fisher, MD, FACC

Westby Fisher

This morning I sit quietly in my hotel room, contemplating the day ahead at the 2013 Heart Rhythm Society Scientific Sessions in Denver. Emotions clash.

Filed Under: Blog, News Well Tagged With: Conference coverage, Dr. Wes, Heart Rhythm Society, HRS 2013

HRS 2013: St. Jude Medical touts independent safety data for next-gen Durata leads

May 9, 2013 By Arezu Sarvestani Leave a Comment

St. Jude Medical logo

Medical device giant St. Jude Medical (NYSE:STJ) landed an important win today after a research team released study results finding that the company’s Durata defibrillator leads proved safe and reliable in an independent review.

Filed Under: News Well Tagged With: Cardiac Rhythm Management, Clinical Trials, Conference coverage, Heart Rhythm Society, HRS 2013, stjudemedical

HRS 2013: Heart failure doesn’t worsen with St. Jude’s recalled QuickSite CRT leads

May 9, 2013 By Brad Perriello Leave a Comment

HRS 2013: Heart failure doesn't worsen with St. Jude Medical's recalled QuickSite and QuickFlex leads

Filed Under: News Well Tagged With: Cardiac Rhythm Management, Guthrie Clinic, Heart Rhythm Society, HRS 2013, stjudemedical

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS